Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen

British Journal of Haematology

Volumn 133, Issue 6, 2006, Pages 649-654

  Resnick, Igor B ^a   Aker, Memet ^a   Shapira, Michael Y ^a   Tsirigotis, Panagiotis D ^a   Bitan, Menachem ^a   Abdul Hai, Ali ^a   Samuel, Simcha ^a   Ackerstein, Aliza ^a   Gesundheit, Benjamin ^a   Zilberman, Irina ^a   Miron, Svetlana ^a   Yoffe, Luba ^a   Lvovich, Alex ^a   Slavin, Shimon ^a   Or, Reuven ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Fludarabine; Non myeloablative HSCT; Severe aplastic anaemia

Indexed keywords

ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; FLUDARABINE; IMMUNOGLOBULIN; PREDNISONE; STEROID; THYMOCYTE ANTIBODY; TYMOGLOBULINE;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; APLASTIC ANEMIA; ASPERGILLOSIS; BACTEREMIA; BLOOD TRANSFUSION; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL ARTICLE; DEATH; DISEASE SEVERITY; DRUG TREATMENT FAILURE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GRAFT FAILURE; HEPATOSPLENIC CANDIDIASIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INVASIVE ASPERGILLOSIS; ISRAEL; KARNOFSKY PERFORMANCE STATUS; LIFESTYLE; MALE; MUCOSA INFLAMMATION; MYCOSIS; NASAL SINUS ASPERGILLOSIS; NONMYELOABLATIVE CONDITIONING; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; NOSE INFECTION; OUTCOME ASSESSMENT; PARANASAL SINUS DISEASE; PARVOVIRUS; PARVOVIRUS INFECTION; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; CHILD; CYCLOPHOSPHAMIDE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MUCOSITIS; OPPORTUNISTIC INFECTIONS; PILOT PROJECTS; QUALITY OF LIFE; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VIDARABINE;

EID: 33646671932     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06084.x     Document Type: Review

References (25)

1. Bacigalupo A. Oneto R. Bruno B. Socie G. Passweg J. Locasciulli A. Van Lint M.T. Tichelli A. McCann S. Marsh J. Ljungman P. Hows J. Marin P. Schrezenmeier H. 2000 Current results of bone marrow transplantation in patients with acquired severe aplastic anaemia. Report of the European Group for Blood and Marrow Transplantation Acta Hematologica 13 19 25
2. Bacigalupo A. Locatelli F. Lamino E. Marsh J. Socie G. Manry S. Prete A. Locasciulli A. Cesaro S. Passweg J. 2005 Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anaemia: a report from the EBMT-SAA Working Party Bone Marrow Transplantation 36 947 950
3. Brodsky R.A. Jones R.J. 2005 Aplastic anaemia The Lancet 365 1647 1656
4. Castro-Malaspina H. Childs B. Laver J. Shank B. Brochstein J. Gillio A. Flomenberg N. Young J. Boulad F. Black P. 1994 Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anaemia International Journal of Radiation Oncology, Biology, Physics 29 847 854
5. Champlin R.E. Ho W.G. Nimer S.D. Gajewski J.G. Selch M. Burnison M. Holley G. Yam P. Petz L. Winston D.J. 1990 Bone marrow transplantation for severe aplastic anaemia. Effect of a preparative regimen of cyclophosphamide- low-dose total-lymphoid irradiation and post-transplant methotrexate- methotrexate therapy Transplantation 49 720 724
6. Feig S.A. Champlin R. Arenson E. Yale C. Ho W. Tesler A. Gale R.P. 1983 Improved survival following bone marrow transplantation for aplastic anaemia British Journal of Haematology 54 509 517
7. Glucksberg H. Storb R. Fefer A. Buckner C.D. Neiman P.E. Clift R.A. Lerner K.G. Thomas E.D. 1974 Clinical manifestations of graft versus host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 18 295 304
8. Gupta V. Ball S.E. Yi O.L. Sage D. McCann S.R. Lawler M. Ortin M. Freires M. Hale G. Waldmann H. Gordon-Smith E.C. Marsh J.C. 2004 Favourable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anaemia Biology of Blood and Marrow Transplantation 10 867 876
9. Haselberger M.B. Schwinghammer T.L. 1995 Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy Annals of Pharmacotherapy 29 918 921
10. Huss R. Deeg H.J. Gooley T. Bryant E. Leisenring W. Clift R. Buckner C.D. Martin P. Storb R. Appelbaum F.R. 1996 Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anaemia or chronic myelogenous leukaemia Bone Marrow Transplantation 18 767 776
11. Marsh J.C. Ball S.E. Darbyshire P. Gordon-Smith E.C. Keidan A.J. Martin A. McCann S.R. Mercieca J. Oscier D. Roques A.W. Yin J.A. 2003 British Committee for Standards in Haematology. Guidelines for the diagnosis and management of acquired aplastic anaemia British Journal of Haematology 123 782 801
12. McCann S.R. Bacigalupo A. Gluckman E. Hinterberger W. Hows J. Ljungman P. Marin P. Nissen C. van't Veer Kerthof E. Raghavachar A. 1994 Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the aplastic anaemia working party of the European Bone Marrow Transplant Group Bone Marrow Transplantation 13 233 237
13. Nagler A. Or R. Naparstek E. Varadi G. Slavin S. 2000 Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation Experimental Hematology 28 1096 1104
14. Nakamura Y. Leppert M. O'Connell P. Wolff R. Holm T. Culver M. Martin C. Fujimoto E. Hoff M. Kumlin E. 1987 Variable number of tandem repeat (VNTR) markers for human gene mapping Science 235 1616 1622
15. Passweg J.R. Socie G. Hinterberger W. Bacigalupo A. Biggs J.C. Camitta B.M. Champlin R.E. Gale R.P. Gluckman E. Gordon-Smith E.C. Hows J.M. Klein J.P. Nugent M.L. Pasquini R. Rowlings P.A. Speck B. Tichelli A. Zhang M.J. Horowitz M.M. Bortin M.M. 1997 Bone marrow transplantation for severe aplastic anaemia: has outcome improved Blood 90 858 864
16. Pugatsch T. Oppenheim A. Slavin S. 1996 Improved single-step PCR assay for sex identification post allogeneic sex-mismatched BMT Bone Marrow Transplantation 17 273 275
17. Resnick I.B. Shapira M.Y. Slavin S. 2005 Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases Transplant Immunology 14 207 219
18. Sanders J.E. Whitehead J. Storb R. Buckner C.D. Clift R.A. Mickelson E. Appelbaum F.R. Bensinger W.I. Stewart P.S. Doney K. 1986 Bone marrow transplantation experience for children with aplastic anaemia Pediatrics 77 179 186
19. Slavin S. Nagler A. Naparstek E. Kapelushnik Y. Aker M. Cividalli G. Varadi G. Kirschbaum M. Ackerstein A. Samuel S. Amar A. Brautbar C. Ben-Tal O. Eldor A. Or R. 1998 Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant haematological diseases Blood 91 756 763
20. Storb R. Prentice R.L. Thomas E.D. 1977 Marrow transplantation for treatment of aplastic anaemia. An analysis of factors associated with graft rejection New England Journal of Medicine 296 61
21. Storb R. Sanders J.E. Pepe M. Anasetti C. Appelbaum F.R. Buckner C.D. Deeg H.J. Doney K. Hansen J. Martin P. 1991 Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anaemia treated with cyclophosphamide and HLA-identical marrow grafts Blood 78 1144 1155
22. Storb R. Etzioni R. Anasetti C. Appelbaum F.R. Buckner C.D. Bensinger W. Bryant E. Clift R. Deeg H.J. Doney K. 1994 Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anaemia Blood 84 941 949
23. Storb R. Blume K.G. O'Donnell M.R. Chauncey T. Forman S.J. Deeg H.J. Hu W.W. Appelbaum F.R. Doney K. Flowers M.E. Sanders J. Leisenring W. 2001 Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anaemia for allogeneic marrow transplantations: the experience in four centres Biology of Blood and Marrow Transplantation 7 39 44
24. Travis L.B. Curtis R.E. Glimelius B. Holowaty E.J. Van Leeuwen F.E. Lynch C.F. Hagenbeek A. Stovall M. Banks P.M. Adami J. 1995 Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma Journal of the National Cancer Institute 87 524 530
25. Young N.S. 1995 Aplastic anaemia The Lancet 346 228 232